Home » Autogenomics

Autogenomics

Jun 06, 2018

FDA Grants Breakthrough Designation for AutoGenomics' Infiniti Neural Response Panel

The designation will help the company accelerate the process of bringing the opioid addiction risk test through regulatory review and clearance.

Aug 29, 2017

Prescient Medicine Launches Addiction Risk Test Developed With AutoGenomics

Premium

The company joins others in a still-controversial setting, hoping to market its test to help guide the prescription of narcotic pain medications.

Sep 09, 2016

WuXi to Distribute AutoGenomics' MDx System in China

The companies will also collaborate on new diagnostic technologies and products that are specifically designed for Chinese patients.

Jul 24, 2015

AutoGenomics to Withdraw Planned IPO; Eyes Launch of New MDx Platform in Q1 2016

Premium

The firm will withdraw its planned IPO after being told that it would have to take a 30 to 40 percent discount to its valuation, its CEO said. 

Feb 04, 2015

AutoGenomics Sets Price Range for Planned IPO, Anticipates up to $46.6M in Proceeds

The company said it plans to offer 3.75 million shares of its common stock and expects to fetch between $11 and $13 per share in its IPO.

Oct 08, 2014

AutoGenomics Seeks to Raise $60M in IPO

NEW YORK (GenomeWeb) – Molecular diagnostics firm AutoGenomics has refiled for an initial public offering, less than one year after it pulled earlier plans to go public.

Jul 09, 2014

Genomas, Autogenomics Codeveloping Multiplex Genetic Test for Statin Efficacy and Adverse Events

Premium

Originally published July 8.

Jul 07, 2014

Genomas, AutoGenomics Partner to Advance Dx to Personalize Statin Treatments

NEW YORK (GenomeWeb) – Molecular diagnostics firm AutoGenomics and personalized healthcare company Genomas have signed an agreement to develop genetic tests and DNA-guided diagnostic systems to aid in the selection of statins to improve treatment of heart disease, obesity, and diabetes.

Apr 08, 2014

IP Watch: Epigenomics, Fluidigm, Sony, Life Tech, Others Win US Patents

Premium

Korea Institute of Science and Technology has been awarded

Nov 04, 2013

MDx Firm AutoGenomics Withdraws IPO

NEW YORK (GenomeWeb News) – Molecular diagnostics firm AutoGenomics filed with the US Securities and Exchange Commission to officially withdraw a planned initial public offering.

Pages

The Scan

Mysterious Third Group

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

This Week in Science

In Science this week: reduction in bee phylogenetic diversity, and more.

In the Past

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

New Bases, New Drugs

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.